WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2026 Issue has been successfully launched on FEBRUARY 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR February 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

UPPER GASTROINTESTINAL BLEEDING: A COMPARATIVE STUDY BETWEEN LIBERAL AND RESTRICTIVE TRANSFUSION STRATEGIES

*Tahseen Ali Raheemah (MBChB, CABEM), Firas Kahttan Abbas (MBChB, CJBAEM)

ABSTRACT

Background: Upper gastrointestinal bleeding is a prevalent condition with a mortality rate that is as high as 15%. The optimal red blood cell transfusion strategy in acute gastrointestinal bleeding is debated. Aim of study: This study aims to compare between patients with upper GI bleeding receiving restrictive and liberal transfusion strategies regarding in hospital management, complications, overall survival, and adverse outcomes. Patients and methods: This is an analytic prospective cohort study that included 227 patients and was conducted in Baghdad Teaching Hospital/ Medical city, Baghdad. The data was collected from the 1st of January 2023 to the 1st of January 2024. All adult patients (>18 years) diagnosed with presenting with upper gastrointestinal bleeding to the emergency department during the study period were included in the study. At admission, patients were assigned to undergo either liberal transfusion protocol or restrictive protocol. In the restrictive-strategy group, the hemoglobin threshold for transfusion was 7 g per deciliter. In the liberal-strategy group, the hemoglobin threshold for transfusion was 9 g per deciliter. The primary outcome measure was the rate of death in the emergency department. Secondary outcomes included the rate of further bleeding and the rate of in-hospital complications. Results: Patients of the liberal group were significantly more likely to need variceal banding (P=0.002) and octreotide injection (P=0.008). Overall emergency department mortality was seen in 3 (2.7%) cases of the restrictive group and 12 (10.4%) cases of the liberal group, with the difference being statistically significant (P value = 0.030). A statistically significant difference was detected between both study groups regarding the incidence of transfusion-associated circulatory overload and pulmonary edema. Conclusion: According to the results of the current study, patients who underwent transfusion with a restrictive strategy exhibited a notable decrease in the requirement for banding and octreotide therapy. Additionally, there was an enhancement in the overall survival and a decrease in transfusion-related complications.

[Full Text Article] [Download Certificate]